A method of preparing enantiopure hydroxy--butyrolactones containing multiple contiguous stereocentres in high yield with good diastereoselectivity has been developed. Osmium tetroxide mediated dihydroxylation of a range of -alkenyl--hydroxy-N-acyloxazolidin-2-ones results in formation of triols that undergo spontaneous intramolecular 5-exo-trig cyclisation reactions to provide hydroxy--butyrolactones. The stereochemistry of these hydroxy--butyrolactones has been established using NOE spectroscopy, which revealed that 1-substituted, 1,1-disubstituted, (E)-1,2-disubstituted, (Z)-1,2-disubstituted, and 1,1,2-trisubstituted alkenes undergo dihydroxylation with anti-diastereoselectivity, whilst 1,2,2-trisubstituted systems afford syn-diastereoisomers. The synthetic utility of this methodology has been demonstrated for the asymmetric synthesis of the natural product 2-deoxy-Dribonolactone.
Introduction
Enantiomerically pure trisubstituted -butyrolactones are found as fragments in a large number of natural products that display a broad range of biological activities 1 and a wide range of methodology has been developed for their asymmetric synthesis. 2 Hydroxy--butyrolactones represent an important subset of this type of natural product 3 and they have also been shown to be important chiral building blocks for natural product synthesis. Jenkinson et al. prepared synthetically useful and highly functionalised sugar-lactones using directed osmium dihydroxylations of chain extended ribulose and erythrose derivatives. 5b We have previously reported that -alkenyl--hydroxy-N-acyloxazolidin-2-ones (1) undergo efficient epoxidation/lactonisation reactions with catalytic VO(acac) 2 and a stoichiometric equivalent of tert-butylhydroperoxide to afford hydroxy--butyrolactones (3) (Scheme 1). It is proposed that an unstable epoxide (2) is generated with high levels of diastereocontrol, which is then ring-opened by intramolecular nucleophilic attack of the exocyclic carbonyl fragment that gives clean inversion of configuration at the C 5 position. Hydrolysis of the resulting iminium species affords a highly functionalised hydroxy--butyrolactone skeleton containing multiple contiguous stereocentres. 6 Scheme 1. Epoxidation/lactonisation sequence with inversion of configuration at C 5 to form a hydroxy--butyrolactone 3 containing three contiguous stereocentres.
As this epoxidation/lactonisation sequence leads to inversion of configuration at the C 5 position, it was decided to investigate an osmium catalysed dihydroxylation/lactonisation protocol in order to access complementary diastereoisomers of this type of hydroxy--butyrolactone (Scheme 2). For example, dihydroxylation of the alkene fragment of the generic aldol substrate 1 with anti-diastereoselectivity to its -hydroxyl group would afford a triol (5) , which would spontaneously lactonise to afford a diastereomeric hydroxy--butyrolactone. The dihydroxylation/lactonisation reaction of acrolein aldol 1c was less diastereoselective, giving a 3:1 mixture of diastereoisomers, with the major diastereoisomer (6c) being formed from dihydroxylation with anti-diastereocontrol in 79% yield (Table 1 , entry 2). It was found that (E)-1,2-disubstituted aldols derived from cinnamaldehyde and crotonaldehyde (1d and 1e respectively) underwent dihydroxylation with greater levels of anti-diastereoselectivity to
give hydroxy--butyrolactones 6d (9:1 dr) and 6e (5:1 dr) in good yields ( derived from 3-methyl-2-butenal proceeded with reduced diastereoselectivity, with the major hydroxy--butyrolactone 6j diastereoisomer having the opposite configuration at C 5 to that observed for the previous examples. Therefore, it follows that the 1,2,2-trisubstituted aldol 1j must preferentially undergo dihydroxylation syn to its -hydroxyl group (5:1 dr) before lactonisation to afford (3S,4S,5R)-hydroxy--butyrolactone 6j in 41% yield (Table 1 , entry 9).
We then decided to investigate the effect of varying the -substituent of the unsaturated aldol on the dihydroxylation/lactonisation reaction. The -phenyl 1,1-disubstituted aldol 1k was prepared using our standard boron aldol protocol and subjected to the standard dihydroxylation/lactonisation conditions. It was found that -phenyl aldol 1k underwent dihydroxylation with good levels of anti-diastereoselectivity (9:1 dr), allowing the corresponding hydroxy--butyrolactone 6k to be isolated in 75% yield (Table 1 , entry 10).
Whilst the vast majority of alkene substitution patterns gave high levels of diastereoselectivity for our dihydroxylation/lactonisation sequence, the (Z)-1,2-disubstituted aldol 1g gave a 2:1 mixture of lactone diastereoisomers. In an attempt to improve the diastereoselectivity, (Z)-1,2-disubstituted aldol 1g was reacted under Sharpless asymmetric dihydroxylation conditions using both AD-mix- and AD-mix- (Scheme 5a and b).
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Remarkably, the 'mismatched' reaction of (Z)-1,2-disubstituted aldol 1g with AD-mix- resulted in dihydroxylation/lactonisation with reversal of diastereoselectivity compared with the reaction using the standard Upjohn conditions. The hydroxy--butyrolactones (6g and 8)
were obtained in 95% yield as a 4:1 mixture of diastereoisomers, with the major lactone (8) being formed as the result of dihydroxylation with syn-diastereoselectivity with respect to the -hydroxyl group of 1g (Scheme 5a). This facial selectivity is consistent with that observed previously by Sharpless et al. for reaction of a simplified (Z)-O-benzyl allylic alcohol with AD-mix-. 11 Pleasingly, the use of AD-mix- resulted in 'matched' enhancement of the diastereoselectivity observed for dihydroxylation under Upjohn conditions, affording the hydroxy--butyrolactones (6g and 8) in 95% yield as a 17:1 mixture of diastereoisomers (Scheme 5b). In this case the major diastereoisomer (6g) obtained is the result of dihydroxylation with anti-diastereoselectivity relative to the -hydroxyl group of 1g, which is again consistent with the results obtained by Sharpless et al. using AD-mix- on related substrates.
Scheme 5. Effect of using Sharpless asymmetric dihydroxylation conditions.
Finally, in order to demonstrate the synthetic utility of our dihydroxylation/lactonisation protocol we decided to apply it to the synthesis of 2-deoxy-D-ribonolactone (11), 12 which is a byproduct of oxidatively damaged DNA. 13 2-Deoxy-D-ribonolactone (11) has also been shown to be a useful synthetic precursor, 14 whilst its nucleoside derivatives are of structural interest because they can potentially act as universal bases and non-hydrogen bonding isosteres of nucleobases for chemical biology applications. 15 Therefore, the boron enolate of -chloropropionyl-N-acyl-oxaolidin-2-one 7c was reacted with acrolein to afford syn-aldol 9 in a 45% yield and in >95% de. Treatment of the -chloro--vinyl-aldol 9 with zinc dust and ammonium chloride in methanol resulted in dechlorination, providing the desired allylic alcohol 10 in 82% yield. 16 The dechlorinated alcohol 10 was then subjected to the standard Upjohn dihydroxylation/lactonisation conditions, to afford 2-deoxy-D-ribonolactone (11) as a 9:1 mixture of diastereoisomers in 87% yield (Scheme 6), 17 whose spectroscopic data was consistent with that reported previously.
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Scheme 6. Asymmetric synthesis of 2-deoxy-D-ribonolactone (11).
Assignment of Stereochemistry
There are many literature examples of directed dihydroxylation reactions of allylic alcohols, with selected examples of dihydroxylations of allylic alcohols with various substitution patterns shown in Scheme 7.
18 Several stereochemical models have been proposed to rationalise the observed diastereoselectivity in dihydroxylation reactions of allylic alcohols, most notably the models described by Kishi, Houk and Vedejs. The modest levels of anti-diastereoselectivity (2:1) observed for the reaction of (Z)-1,2-disubstituted aldol 1g are in contrast with the observations of Donohoe et al., who found that simple (Z)-1,2-disubstituted allylic alcohols gave low levels (2:1) of syn-diastereoselectivity when dihydroxylation was carried out under Upjohn conditions (Scheme 7d). 23b In our case, the configuration of the C 5 stereocentre of the major diasteroisomer of hydroxy--butyrolactone 6g was confirmed by analysis of the 1 H NOE spectrum, which showed a strong interaction between the C 3 proton and the C 5 proton (Figure 1g ). However, the low levels of diastereoselectivity observed in both cases suggest that the directing effect of the allylic alcohol in (Z)-1,2-disubstituted systems is limited, therefore it is unsurprising that different substrates result in different diastereoisomers being formed with poor dr.
The high levels of anti-diastereoselectivity observed for the (E)-1,1,2-trisubstututed aldols (1h and 1i) were consistent with the results of Fronza et al. who found that an acetonide protected allylic alcohol gave dihydroxylation with anti-diastereoselectivity when reacted under Sharpless conditions in the absence of a chiral ligand (Scheme 7e). 24 The configuration of the hydroxy--butyrolactones (6h and 6i) was confirmed by analysis of the 1 H NOE spectra, which showed strong interactions between the proton on C 3 and the C 5 methyl protons as well as strong interactions between the C 3 methyl group and the C 5 CHOH proton in both cases (Figure 1h and 2i).
The dihydroxylation/lactonisation of 1,2,2-trisubstituted aldol 1j proceeded with syndiastereoselectivity, which is consistent with the syn-diastereoselectivity previously observed by Donohoe et. al. for dihydroxylation of 1,2,2-trisubstituted allylic alcohols (Scheme 7f).
23b
The 5R stereochemistry of the major diastereoisomer of hydroxy--butyrolactone 6j was confirmed by a strong interaction in the 1 H NOE spectra between the methyl protons on C 3 and the C 5 proton (Figure 1j ), whilst a vicinal coupling constant between the protons on C 4
and C 5 of 3 J = 7.4 Hz is indicative of a syn-relationship between these protons.
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The -substituent of the aldol product was shown not to affect the stereochemical outcome of the dihydroxylation reaction unduly, with -phenyl 1,1-disubstituted aldol 1k undergoing dihydroxylation with the expected anti-diastereoselectivity (Scheme 7a) to afford hydroxy--butyrolactone 6k, which exhibited the same characteristic interactions in its 1 H NOE Figure 1 . Strong interactions in the 1 H NOE spectra of the hydroxyl--butyrolactones (6a-k).
Of particular relevance to the results described is the previous report of Dias et al., who reported the dihydroxylation/lactonisation of a small series of closely related Evans derived -alkenyl-O-silyl aldol products (14a-d) . Surprisingly, the configuration of the resulting Osilyl--butyrolactones (16a-d) was reported as (3S,4S,5S), which was different to the results we had obtained, with lactones 16b and 16d reported to have arisen from an unprecedented antarafacial dihydroxylation reaction occurring with syn-diastereoselectivity to the -O-silyl hydroxyl group (Scheme 9). 5h,26 Therefore, in order to investigate the effect of the O-silyl group on these dihydroxylation/lactonisation reactions, unsaturated aldol 1a was O-TBS protected using TBS-OTf and 2,6-lutidine and subjected to the standard Upjohn dihydroxylation/lactonisation conditions, which gave O-TBS -butyrolactone 13 in a 3:1 dr.
This mixture was then deprotected using TBAF to give hydroxy--butyrolactone 6a in 65% In light of this result, we propose that both the free hydroxyl and O-silyl protected unsaturated aldol derivatives of 1a undergo dihydroxylation with anti-diastereoselectivity to the stereodirecting group. We therefore suggest that the stereochemical assignments of the Osilyl--butyrolactones (16a-d) previously reported by Dias et al. 5h are incorrect and propose that the configuration of these lactones be reassigned as shown in Scheme 9. 
Conclusions
We have developed a method of preparing enantiomerically pure hydroxy--butyrolactones
The configurations of the resulting hydroxy--butyrolactones (6a-k) have been confirmed by 1 H NOE spectroscopic analysis, which revealed that the diastereoselectivity of these directed dihydroxylation reactions is dependent on the alkene substitution pattern. It was 
Experimental
General: All reactions were performed using starting materials and solvents obtained from commercial sources without further purification using dry solvents under an atmosphere of nitrogen. 1 H NMR spectra were recorded at 250, 300, 400 and 500 MHz and 13 C{ 1 H} NMR spectra were recorded at 75 MHz. Chemical shifts δ are quoted in parts per million and are referenced to the residual solvent peak. NMR peak assignments were confirmed using 2D 1 H COSY where necessary. Chemical shift is reported in parts per million (ppm) and all coupling constants, J, are reported in Hertz (Hz). Infra-red spectra were recorded as thin films or were recorded with internal background calibration in the range 600-4000 cm -1 , using thin films on NaCl plates (film), or KBr discs (KBr) as stated. High resolution mass spectra were recorded in either positive or negative mode using electrospray (ES) ionisation. Optical rotations were recorded with a path length of 1 dm; concentrations (c) are quoted in g/100 mL.
General Procedure for the Acylation of (S)-4-Benzyl-5,5-dimethyloxazolidin-2-one: n-
BuLi (1.1 equiv., 2.5 M solution in hexane) was added to a solution of (S)-4-benzyl-5,5-dimethyloxazolidin-2-one (1 equiv.) in dry THF at -78˚C under nitrogen and was stirred for 30 minutes. The appropriate acid chloride (1.1 equiv.) was added in one portion and the resulting solution was stirred for a further two hours. The reaction was quenched with saturated ammonium chloride and allowed to warm to ambient temperature. The THF was evaporated under reduced pressure, the resulting oil was redissolved in dichloromethane and extracted with brine. The combined organic extracts were dried over MgSO 4 and concentrated to afford the crude product. 4, 152.8, 137.1, 129.2, 128.8, 126.9, 82.3, 63.6, 35.5, 29.5, 28.7, 22.4, 8.5 6, 152.7, 137.0, 133.8, 129.8, 129.2, 128.8, 128.7, 127.3, 126.9, 82.5, 63.9, 41.9, 35.3, 28.7, 22.4 
Non-Commercially Available Aldehydes
(E)-4-(Benzyloxy)but-2-enal: Based on a literature procedure, 27 oxalyl chloride (0.26 mL, 3.1 mmol) was dissolved in dry dichloromethane (10 mL) at -55 ˚C under nitrogen.
Dimethylsulphoxide (0.39 mL, 5.6 mmol) was added and the resulting solution was stirred for two minutes. (Z)-4-(Benzyloxy)but-2-en-1-ol (0.50 g, 2.8 mmol) in dichloromethane (1 mL) was added dropwise to the solution to form a light yellow cloudy mixture, which was stirred for 15 minutes at -55 ˚C. Triethylamine (1.96 mL, 14.0 mmol) was then added and the resulting solution was stirred for a further 15 minutes at -55 ˚C. The thick white slurry was warmed to room temperature and was quenched with the addition of water (10 mL). The layers were separated and the aqueous layer was extracted three times with dichloromethane (20 mL). The combined organic layers were washed with 1 M HCl (10 mL) and saturated General Procedure for the Synthesis of -Alkenyl--hydroxy-N-acyloxazolidin-2-ones: (1.3 equiv.) was added in one portion and the reaction was allowed to warm to ambient temperature overnight. The reaction was quenched with pH 7 buffer solution (Na 2 PO 4 /NaH 2 PO 4 ) (10 mL) and was stirred for ten minutes. Hydrogen peroxide (4 mL) and methanol (8 mL) were then added and the solution was stirred for a further two hours. The methanol was evaporated, the solution diluted with dichloromethane and washed with saturated NaHCO 3 and brine. The combined organic extracts were dried over MgSO 4
and concentrated to afford crude product. 5, 152.6, 150.3, 137.0, 129.5, 129.1, 127.3, 109.9, 82.7, 74.1, 63.8, 41.1, 35.8, 28.8, 25.7, 22.6, 12.5, 11.1 3, 152.2, 146.8, 137.9, 136.7, 129.1, 128.6, 128.4, 127.7, 127.6, 126.8, 113.3, 82.2, 74.5, 73.0, 70.0, 63.3, 41.5, 35.3, 32.7, 28.2, 22.1, 12 8, 137.7, 137.0, 129.5, 129.1, 127.3, 116.8, 82.8, 73.2, 63.8, 42.85, 35.9, 28.8, 22.6, 11.7 ; 1, 152.6, 137.7, 134.1, 129.3, 129.2, 129.1, 127.3, 82.7, 73.4, 63.8, 43.3, 35.9, 32.7, 32.2, 29.6, 29.5, 23.1, 14.5, 12. 
(S)-4-Benzyl-3-((2S,3R,E)-3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyl-oxazolidin-2-one, 1e:
The title compound was prepared according to the general procedure from 9-BBNOTf (5.56 mL, 2.8 mmol), (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 7a (0.61 g, 2.3 mmol), N,N-diisopropylethylamine (0.53 ml, 3.0 mmol) and (E)-crotonaldehyde (0.25 mL, 3.0 mmol) in dichloromethane (50 mL) to afford a crude product as a pale yellow oil.
The crude product was purified using flash silica chromatography to afford (S)-4-benzyl-3- 
(S)-4-Benzyl-3-((2S,3R,E)-6-(benzyloxy)-3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyl
oxazolidin-2-one, 1f: Based on a literature procedure, 27 (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 7a (1.95 g, 7.5 mmol) was dissolved in dry dichloromethane (50 mL) at -10 ˚C under nitrogen and was stirred for 20 minutes. Dibutylboron triflate (8.97 mL, 9.0 mmol, 1.0 M in dichloromethane) was added dropwise followed by triethylamine (1.35 mL, 9.7 mmol) and the resulting solution was stirred for 30 minutes at 0 ˚C. The reaction was cooled to -78 ˚C and (E)-4-(benzyloxy)but-2-enal (1.45 g, 8.2 mmol) was added dropwise.
The solution was stirred at -78 ˚C for 45 minutes and then warmed to 0 ˚C and stirred for a further 3 hours. The reaction was cooled to -10 ˚C and pH 7 buffer solution (Na 2 PO 4 /NaH 2 PO 4 ) (30 mL) was added followed by methanol (24 mL) and hydrogen peroxide (12 mL). The methanol was evaporated, the solution diluted with dichloromethane and washed with saturated NaHCO 3 and brine. The combined organic extracts were dried over MgSO 4 and concentrated. The crude product was purified using flash silica 
(S)-4-Benzyl-3-((2S,3R,Z)-6-(benzyloxy)-3-hydroxy-2-methylhex-4-enoyl)-5,5-dimethyl
oxazolidin-2-one, 1g: Based on a literature procedure, 27 (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 7a (0.50 g, 1.9 mmol) was dissolved in dry dichloromethane (20 mL) at -10 ˚C under nitrogen and was stirred for 20 minutes. Dibutylboron triflate (2.29 mL, 2.3 mmol, 1.0 M in dichloromethane) was added dropwise followed by triethylamine (0.35 mL, 2.5 mmol) and the resulting solution was stirred for 30 minutes at 0 ˚C. The reaction was cooled to -78 ˚C and (Z)-4-(benzyloxy)but-2-enal (0.37 g, 2.1 mmol) was added dropwise.
The solution was stirred at -78 ˚C for 45 minutes and then warmed to 0 ˚C and stirred for a further three hours. The reaction was cooled to -10 ˚C and pH 7 buffer solution (Na 2 PO 4 /NaH 2 PO 4 ) (10 mL) was added followed by methanol (8 mL) and hydrogen peroxide (4 mL). The methanol was evaporated, the solution diluted with dichloromethane and washed with saturated NaHCO 3 and brine. The combined organic extracts were dried over MgSO 4 and concentrated. The crude product was purified using flash silica chromatography 9, 152.6, 138.1, 136.7, 132.1, 129.6, 129.2, 128.7, 128.5, 127.9, 127.8, 126.9, 82.4, 72.5, 69.0, 66.2, 63.4, 43.1, 35.5, 28.4, 22.2. 12.4 
(S)-4-Benzyl-3-((2S,3S,E)-3-hydroxy-2,4-dimethylhept-4-enoyl)-5,5-dimethyloxazolidin-

2-one, 1h:
The title compound was prepared according to the general procedure from 9-BBN-OTf (7.08 mL, 3. 3, 152.7, 137.1, 133.4, 129.5, 129.0, 128.8, 127.2, 82.67, 76.1, 63.8, 41.1, 35.8, 28.7, 22.5, 21.3, 14.4, 13.5, 11.5 6, 152.3, 138.3, 138.1, 136.7, 129.1, 128.6, 128.4, 127.8, 127.6, 126.9, 122.9, 82.4, 75.2, 72.1, 66.2, 63.5, 40.6, 35.3, 28.3, 22.1, 13.6, 10.9 7, 153.0, 137.2, 137.1, 129.5, 129.1, 127.3, 124.5, 82.6, 69.9, 63.8, 43.4, 35.9, 28.6, 26.4, 22.5, 18.8, 12.6 ; IR cm 5, 144.8, 136.9, 134.7, 130.26, 129.4, 129.1, 128.9, 128.4, 127.1, 114.2, 82.5, 63.7, 53.4, 35.3, 28.7, 22.5, 18.7 in acetone/water (8:1, 1.5 mL) followed by addition of NMO (60% by weight in water, 0.07 mL, 0.34 mmol) according to the general procedure to afford the crude product as black oil.
Purification via column chromatography afforded 6b (80 mg, 0.28 mmol, 93%, 10:1 dr 4, 136.5, 128.8, 128.5, 128.3, 87.8, 76.5, 73.9, 66.4, 64.8, 42.9, 30.3, 13.7 4, 134.5, 129.1, 128.7, 127.4, 80.1, 74.9, 70.9, 43.1, 14 OsO 4 (13 mg, 0.05 mmol) was added to a solution of 1e (164 mg, 0.50 mmol) in acetone/water (8:1, 3 mL) followed by addition of NMO (60% by weight in water, 0.09 mL, 0.54 mmol) according to the general procedure to afford the crude product as black oil.
Purification via column chromatography afforded a diastereomeric mixture of 6e major and 6e minor (66 mg, 0.41 mmol, 83% 8, 86.4, 74.9, 66.6, 44.2, 19.9, 12.8 3, 82.9, 76.3, 67.1, 44.6, 19.8, 14.0 6, 137.1, 128.8, 128.4, 128.1, 84.3, 74.6, 74.0, 71.1, 69.3, 43.2, 12.4 Purification via column chromatography afforded the product in 74% yield, 2:1 dr, 6g major (28 mg, 0.11 mmol, 45%) , 6g minor (13 mg, 0.05 mmol, 21%) and a mixture of 6g major and 6g minor (4 mg, 0.15 mmol, 7% 5, 136.9, 128.8, 128.5, 128.2, 83.1, 74.5, 74.3, 70.9, 70.4, 42.7, 12.6 137.3, 128.8, 128.3, 128.1, 79.2, 75.0, 73.9, 71.0, 69.1, 43.8, 13.8 9, 136.6, 128.9, 128.6, 128.3, 87.7, 76.8, 74.3, 74.0, 70.0, 40.6, 13.9, 12.7 OsO 4 (14 mg, 0.05 mmol) was added to a solution of 1j (184 mg, 0.53 mmol) in acetone/water (8:1, 3 mL) followed by addition of NMO (60% by weight in water, 0.10 mL, 0.59 mmol) according to the general procedure to afford the crude product as black oil.
Purification via column chromatography afforded 6j (38 mg, 0.22 mmol, 41% 4, 152.4, 136.5, 129.1, 128.9, 127.1, 83.7, 64.1, 44.0, 35.0, 28.7, 22.4 
9:
The title compound was prepared according to the general procedure from dibutylboron triflate (7.70 mL, 7.7 mmol), (S)-4-benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one 7c (1.97g, 7.0 mmol) , N,N-diisopropylethylamine (1.58 mL, 9.1 mmol) and acrolein (0.61 mL, 9.1 mmol) in dichloromethane (15 mL) to afford a crude product as a pale yellow oil.
The crude product was purified using flash silica chromatography [1:4 EtOAc:Petroleum ether, R f 0.27] to afford (S)-4-benzyl-3-((2S,3R)-2-chloro-3-hydroxypent-4-enoyl)-5,5-dimethyloxazolidin-2-one 9 (1.07g, 3.2 mmol, 45%) as a colourless oil. 1 9, 152.0, 136.4, 135.0, 129.1, 128.8, 127.0, 118.9, 83.3, 72.9, 64.0, 59.1, 34.9, 28.5, 22 3, 152.7, 138.8, 136.8, 129.1, 128.9, 127.0, 115.5, 82.7, 68.9, 63.5, 42.6, 35.6, 28.6, 22.3 Purification via column chromatography afforded 11 (76 mg, 0.57 mmol, 87%, 9:1 dr). 5, 91.0, 70.6, 63.4, 
